Influence of demographic and clinical variables on the ETP-based nAPCsr
| Variable . | B . | P . |
|---|---|---|
| Sex | 0.083 | .855 |
| Age | 0.004 | .808 |
| Hydroxyurea | −0.856 | .090 |
| Aspirin | −0.574 | .261 |
| JAK2V617F | 1.189 | .015 |
| Platelet count | 0.000 | .728 |
| White blood cell count | 0.055 | .279 |
| Hematocrit | 0.945 | .163 |
| Variable . | B . | P . |
|---|---|---|
| Sex | 0.083 | .855 |
| Age | 0.004 | .808 |
| Hydroxyurea | −0.856 | .090 |
| Aspirin | −0.574 | .261 |
| JAK2V617F | 1.189 | .015 |
| Platelet count | 0.000 | .728 |
| White blood cell count | 0.055 | .279 |
| Hematocrit | 0.945 | .163 |
Multiple regression analysis included sex (male = 0; female = 1), age, disease treatment (no = 0; yes = 1), history of thrombosis (no = 0; yes = 1), JAK2V617F mutational status (negative = 0; positive = 1), platelet and white blood cell counts, and hematocrit as independent variables and the ETP-based nAPCsr as the dependent variable.